Feed Preview

Neuromuscular Junction Diseases

Neuromuscular Junction Diseases diagram by Arkadiusz Wos, Shutterstock
Arkadiusz Wos, Shutterstock

Diseases of the neuromuscular junction cause skeletal muscle fatigue and include inherited and acquired disorders that affect presynaptic, intrasynaptic or postsynaptic components. Discover the latest research on neuromuscular junction diseases here.

Top 20 most recent papers
bioRxiv

Downregulation of both mismatch repair and non-homologous end-joining pathways in hypoxic brain tumour cell lines

bioRxivJanuary 15, 2020
Sophie CowmanViolaine See
4
The Journal of Clinical Investigation

Profilin1 delivery tunes cytoskeleton dynamics towards CNS axon regeneration

The Journal of Clinical InvestigationJanuary 17, 2020
Rita Pinto-CostaMonica M Sousa
Journal of Neuroimmunology

Neuronal antibody detection and improved lung cancer prediction in Lambert-Eaton myasthenic syndrome

Journal of NeuroimmunologyJanuary 18, 2020
Paul MaddisonBethan Lang
1
Journal of the Neurological Sciences

Isolated seizure as initial presentation of GABAA receptor antibody-associated encephalitis

Journal of the Neurological SciencesJanuary 19, 2020
Masanori KuriharaShoji Tsuji
Indian Journal of Ophthalmology

Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus

Indian Journal of OphthalmologyJanuary 16, 2020
Taraprasad DasSPEED Study group
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

Late-onset myasthenia gravis successfully treated with local resection of cervical ectopic thymoma

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaJanuary 14, 2020
Teruhiko SekiguchiSatoshi Orimo
Cells

Methylglyoxal-Dependent Glycative Stress and Deregulation of SIRT1 Functional Network in the Ovary of PCOS Mice

CellsJanuary 18, 2020
Giovanna Di EmidioCarla Tatone
Bioorganic & Medicinal Chemistry

3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line

Bioorganic & Medicinal ChemistryJanuary 16, 2020
Alessio MalacridaGabriella Nicolini
Developmental Neurobiology

Target-Dependent Retrograde Signaling Mediates Synaptic Plasticity at the Drosophila Neuromuscular Junction

Developmental NeurobiologyJanuary 18, 2020
Brett BerkeHaig Keshishian
2
Orphanet Journal of Rare Diseases

Out-of-pocket expenses for myasthenia gravis patients in China: a study on patients insured by basic medical insurance in China, 2013-2015

Orphanet Journal of Rare DiseasesJanuary 16, 2020
Tao-Yu LinRui Min
European Journal of Physical and Rehabilitation Medicine

The ICF-CY as a framework for the management of spinal muscular atrophy in the era of gene therapy: a proof-of-concept study

European Journal of Physical and Rehabilitation MedicineJanuary 16, 2020
Antonio TrabaccaLuciana Losito
Cells

Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging

CellsJanuary 17, 2020
Maria-Eleni Anagnostou, Russell T Hepple
17
Scientific Reports

Postprandial Metabolism is Impaired in Overweight Normoglycemic Young Adults without Family History of Diabetes

Scientific ReportsJanuary 17, 2020
A Aneesh KumarAbdul Jaleel
4
Scientific Reports

Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome

Scientific ReportsJanuary 17, 2020
Osama A A AhmedMahmoud M El-Mas
Scientific Reports

POU domain motif3 (Pdm3) induces wingless (wg) transcription and is essential for development of larval neuromuscular junctions in Drosophila

Scientific ReportsJanuary 18, 2020
Yeon Kim, Kyung-Ok Cho
2
Thoracic Cancer

Amyloid deposition in thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in a patient with myasthenia gravis: A case report

Thoracic CancerJanuary 17, 2020
Seulgi YouYoung W Koh
BMC Neurology

Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease

BMC NeurologyJanuary 11, 2020
Carina WattmoOskar Hansson
1
São Paulo Medical Journal = Revista Paulista De Medicina

Frailty-associated factors among Brazilian community-dwelling elderly people: longitudinal study

São Paulo Medical Journal = Revista Paulista De MedicinaJanuary 16, 2020
Maycon Sousa Pegorari, Darlene Mara Dos Santos Tavares
American Family Physician

Muscle Weakness in Adults: Evaluation and Differential Diagnosis

American Family PhysicianJanuary 16, 2020
Scott T Larson, Jason Wilbur
6
Revista de neurologia

Myasthenia gravis associated with nivolumab

Revista de neurologiaJanuary 14, 2020
B Miñón-FernándezJ Bárcena-Llona

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromuscular-junction-diseases/96eef402-05f4-49bd-aa1d-7fce351f28d0